Comparison of VEGF levels between the NSCLC and control groups
Group
Bronchial Wash VEGF
Serum VEGF
Mean ± SD (pg/mL)
p-value
Mean ± SD (pg/mL)
p-value
NSCLC
675.45 ± 738.1
0.010
834.51 ± 653.1
< 0.001**
Control
316.03 ± 188.4
416.19 ± 272.7
VEGF: Vascular Endothelial Growth Factor; NSCLC: Non-small Cell Lung Carcinoma; SD: standard deviation; ** Mann-Whitney test
Declarations
Acknowledgments
We would like to thank all the staff of the Department of Pulmonology and Respiratory, Faculty of Medicine, Hasanuddin University, Wahidin Sudirohusodo General Hospital, and Hasanuddin University Medical Research Unit (HUM-RC) for their cooperation during the course of this research.
Author contributions
NMW: Conceptualization, Investigation, Data curation, Formal analysis, Writing—original draft, Writing—review & editing. AS: Conceptualization, Investigation, Writing—review & editing, Supervision. HAP: Conceptualization, Investigation, Validation, Writing—review & editing, Supervision. HI, NL, and BN: Investigation, Writing—review & editing, Supervision. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
This study received ethical clearance from Hasanuddin University Faculty of Medicine Ethics Commission (No.692/UN.4.6.4.5.31/PP36/2023).
Consent to participate
Informed consent to participate in the study was obtained from all participants.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer.Contemp Oncol (Pozn). 2021;25:45–52. [DOI] [PubMed] [PMC]
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021;71:209–49. [DOI] [PubMed]
Salmani Javan E, Lotfi F, Jafari-Gharabaghlou D, Mousazadeh H, Dadashpour M, Zarghami N. Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation.Asian Pac J Cancer Prev. 2022;23:519–27. [DOI] [PubMed] [PMC]
Samadzadeh S, Mousazadeh H, Ghareghomi S, Dadashpour M, Babazadeh M, Zarghami N. In vitro anticancer efficacy of Metformin-loaded PLGA nanofibers towards the post-surgical therapy of lung cancer.J Drug Deliv Sci Tec. 2021;61:102318. [DOI]
Alevizakos M, Kaltsas S, Syrigos KN. The VEGF pathway in lung cancer.Cancer Chemother Pharmacol. 2013;72:1169–81. [DOI] [PubMed]
Yao J, Shao Y, Wang J, Li Y, Yang H, Liu J, et al. Evaluation of diagnostic and predictive values of the serum VEGF-A level and systemic immune-inflammation index in small cell lung cancer.J Cancer. 2021;12:1356–64. [DOI] [PubMed] [PMC]
Matsuyama W, Hashiguchi T, Mizoguchi A, Iwami F, Kawabata M, Arimura K, et al. Serum Levels of Vascular Endothelial Growth Factor Dependent on the Stage Progression of Lung Cancer.Chest. 2000;118:948–51. [DOI] [PubMed]
Cao C, Sun S, Lv D, Chen Z, Ding Q, Deng Z. Utility of VEGF and sVEGFR-1 in Bronchoalveolar Lavage Fluid for Differential Diagnosis of Primary Lung Cancer.Asian Pac J Cancer Prev. 2013;14:2443–6. [DOI] [PubMed]
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging.CA Cancer J Clin. 2017;67:93–9. [DOI] [PubMed]
Enzyme immunoassay for the quantitaive determination of human Vascular Edothelial Growth Factor-A (VEGF-A) in human serum, plasma and cell culture supernatant [Internet].IBL International Corp; c2011 [cited 2024 Mar 4]. Available from: https://novamedline.com/files/7c510806-5a3a-4f1a-bbab-77dc130597d7.pdf
Chen T, Zhou F, Jiang W, Mao R, Zheng H, Qin L, et al. Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patients.J Thorac Dis. 2019;11:2251–66. [DOI] [PubMed] [PMC]
Putra DH, Wulandari L, Mustokoweni S. Profile of Non-Small Cell Lung Cancer Carcinoma (NSCLC) patients at Dr. Soetomo Hospital.Medicine. 2016;8:30–4. Indonesian.
Rodak O, Peris-Díaz MD, Olbromski M, Podhorska-Okołów M, Dzięgiel P. Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy.Cancers (Basel). 2021;13:4705. [DOI] [PubMed] [PMC]
de Groot P, Munden RF. Lung Cancer Epidemiology, Risk Factors, and Prevention.Radiol Clin North Am. 2012;50:863–76. [DOI] [PubMed]
Jose NK, Soman B, Thulaseedharan JV, Varghese BT, Thomas S, Tom JJ, et al. Demographic and clinical characteristics of primary lung cancer patients in Kerala: Analysis of data from six teaching centers.J Family Med Prim Care. 2023;12:2501–6. [DOI] [PubMed] [PMC]
Furrukh M. Tobacco Smoking and Lung Cancer: Perception-changing facts.Sultan Qaboos Univ Med J. 2013;13:345–58. [PubMed] [PMC]
Löfling L, Karimi A, Sandin F, Bahmanyar S, Kieler H, Lambe M, et al. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.Acta Oncol. 2019;58:1618–27. [DOI] [PubMed]
Xu C, Zou J, Li L, Yuan Q, Wang W. Elevated serum Cripto-1 and VEGF levels in patients with non-small cell lung cancer.FASEB Bioadv. 2022;4:539–46. [DOI] [PubMed] [PMC]
Lai Y, Wang X, Zeng T, Xing S, Dai S, Wang J, et al. Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer.J Cancer. 2018;9:1538–47. [DOI] [PubMed] [PMC]
Dai M, Hua C, Wang M, Gao L, Jiang L, Liu Y. Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance.Eur J Med Res. 2022;27:299. [DOI] [PubMed] [PMC]
Chakra M, Pujol JL, Lamy P, Bozonnat MC, Quantin X, Jacot W, et al. Circulating Serum Vascular Endothelial Growth Factor is Not a Prognostic Factor of Non-small Cell Lung Cancer.J Thorac Oncol. 2008;3:1119–26. [DOI] [PubMed]
